...
首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >Synthesis of ~(14)C-labeled piperidines and application to synthesis of (~(14)C)SCH 351125, a CCR5 receptor antagonist
【24h】

Synthesis of ~(14)C-labeled piperidines and application to synthesis of (~(14)C)SCH 351125, a CCR5 receptor antagonist

机译:〜(14)C标记的哌啶的合成及其在CCR5受体拮抗剂(〜(14)C)SCH 351125的合成中的应用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

l-Benzyl-4-hydroxy[2-~(14)C]piperidine, a useful intermediate in labeled compound synthesis, was prepared from [~(14)C]formaldehyde in high yield. The distribution pattern of ~(14)C in the product is consistent with a mechanism involving reversible iminium ion formation and rapid equilibration of the iminium ion through a cationic aza-Cope rearrangement. These steps precede the rate-determining intramolecular cyclization step. SCH 351125 is a potent, selective CCR5 receptor antagonist with potential as a treatment for HIV infection. [~(14)C]SCH 351125, required for metabolism studies, was prepared from l-benzyl-4-hydroxy[2-~(14)C]piperidine in six steps. [~(14)C]SCH 351125 is a mixture of four atropisomers. Preparation of [~(14)C]SCH 351125 besylate salt of the desired atropisomer pair is also described.
机译:由[〜(14)C]甲醛高产率地制备1-苄基-4-羟基[2-〜(14)C]哌啶,该化合物是标记化合物合成中有用的中间体。产物中〜(14)C的分布模式与涉及可逆亚胺离子形成和通过阳离子氮杂-Cope重排快速平衡亚胺离子的机理一致。这些步骤在速率确定分子内环化步骤之前。 SCH 351125是一种有效的选择性CCR5受体拮抗剂,具有治疗HIV感染的潜力。代谢研究所需的[〜(14)C] SCH 351125是由1-苄基-4-羟基[2-〜(14)C]哌啶制备的,分六个步骤进行。 [〜(14)C] SCH 351125是四种阻转异构体的混合物。还描述了所需阻转异构体对的[〜(14)C] SCH 351125苯磺酸盐的制备。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号